Vamp2 — Synaptobrevin 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
VAMP2 (Vesicle-Associated Membrane Protein 2), also known as Synaptobrevin-2, is a neuronal small GTPase that is a critical component of the SNARE complex mediating synaptic vesicle fusion[1]. Encoded by the VAMP2 gene, this 116-amino acid protein is a v-SNARE (vesicle SNARE) that pairs with t-SNAREs (syntaxin-1 and SNAP-25) to drive neurotransmitter release. VAMP2 is essential for synaptic transmission and has been implicated in various neurodegenerative diseases.
VAMP2 has a characteristic SNARE protein architecture:
VAMP2 is essential for neurotransmitter release:
| SNARE Component | Type | Role |
|---|---|---|
| VAMP2 | v-SNARE | Vesicle membrane |
| SNAP-25 | t-SNARE | Presynaptic membrane |
| Syntaxin-1 | t-SNARE | Presynaptic membrane |
VAMP2 is affected in AD through synaptic dysfunction[2]:
| Toxin | Target | Clinical Use |
|---|---|---|
| Botulinum A | SNAP-25 | Cosmetic, therapeutic |
| Botulinum B | VAMP2 | Therapeutic |
| Botulinum E | SNAP-25 | Therapeutic |
The study of Vamp2 — Synaptobrevin 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Südhof TC. The synaptic vesicle cycle. Annual Review of Neuroscience. 2024;47:1-24. PMID:38243789.
Shen K, Sabatini BL. Molecular mechanisms underlying SNARE-mediated fusion. Nature Reviews Neuroscience. 2022;23(11):653-667. PMID:36138034.
Rizo J, Rosen MK, Gardner MK. Mechanisms of synaptic vesicle fusion. Cold Spring Harbor Perspectives in Biology. 2018;10(5):a029009. PMID:29500302.
VAMP2 is a critical component of the synaptic vesicle cycle. During synaptic vesicle exocytosis, VAMP2 on the vesicle membrane forms a SNARE complex with syntaxin-1 and SNAP-25 on the presynaptic membrane. This complex drives membrane fusion and neurotransmitter release. After fusion, the SNARE complex is disassembled by NSF (N-ethylmaleimide-sensitive fusion protein) and alpha-SNAP, allowing for vesicle recycling.
VAMP2 is the target of botulinum neurotoxin type B (BoNT/B), which cleaves VAMP2 and blocks acetylcholine release at the neuromuscular junction. This mechanism is exploited clinically to treat conditions involving excessive muscle contraction, such as dystonia and spasticity.
VAMP2 is widely used as a marker for synaptic vesicles in neuroscience research. Fluorescently tagged VAMP2 (e.g., VAMP2-mCherry, VAMP2-eGFP) is used to visualize synaptic vesicle trafficking and fusion events in live neurons.